Neuromodulation
This presentation is the property of its rightful owner.
Sponsored Links
1 / 11

Neuromodulation Market to Reach $11,717 Million by 2022 PowerPoint PPT Presentation


  • 25 Views
  • Uploaded on
  • Presentation posted in: Industry

Neuromodulation Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", projects that the world neuromodulation market is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. External neuromodulators are projected to grow with the fastest CAGR of 14.7%, as they are used externally by the body and hence the risks of implantation can be reduced. Transcutaneous Electrical Nerve Stimulation (TENS) devices occupy over three-fourths share of external neuromodulation devices. View more about report at: https://www.alliedmarketresearch.com/neurostimulation-devices-market

Download Presentation

Neuromodulation Market to Reach $11,717 Million by 2022

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Neuromodulation market to reach 11 717 million by 2022

Neuromodulation

Market

Global Opportunity Analysis and Industry Forecast,

2014 - 2022

Page No: 127

Publish: 2016


Neuromodulation market to reach 11 717 million by 2022

NEUROMODULATION MARKET

OVERVIEW

  • Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. This is in contrast to classical synaptic transmission, in which one presynaptic neuron directly influences a single postsynaptic partner.

  • Amongst the internal neuromodulation devices, spinal cord stimulation (SCS) is highest generator in the global market, owing to the growing number of product approvals and positive clinical outcomes. 

  • A new report published by Allied Market Research, titled, "Neuromodulation Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", projects that the world neuromodulation market is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. 


Neuromodulation market to reach 11 717 million by 2022

NEUROMODULATION MARKET KEY FINDINGS

  • Spinal cord stimulation (SCS) segment generated the highest revenue in 2015, and is projected to grow at a CAGR of 12.1% during the forecast period.

  • Metallic biomaterial is the major component of neurostimulators.

  • Repetitive Transcranial Magnetic Stimulation (RTMS) segment is expected grow at a CAGR of 16.0%.

  • By country, the U.S. led the global neuromodulation market.

  • Germany accounted for about one-third share of the European neuromodulation market in 2015.


Neuromodulation market to reach 11 717 million by 2022

KEY BENEFITS OF THE REPORT

  • The study provides an in-depth analysis of the world neuromodulation market with current trends and future estimations to elucidate the imminent investment pockets.

  • The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

  • The report provides actual historical figures for 2014 and 2015 and provides Y-o-Y forecasts for 2016 to 2022, considering 2015 as base year.

  • SWOT analysis studies the internal environment of the leading companies for strategy formulation.


Neuromodulation market to reach 11 717 million by 2022

NEUROMODULATION MARKET SEGMENTS


Neuromodulation market to reach 11 717 million by 2022

KEY PLAYERS IN INDUSTRY

  • Medtronic plc

  • St. Jude Medical Inc

  • LivaNovaPLC

  • Boston Scientific Corporation

  • AlevaNeurotherapeuticsSA

  • BioControlMedical

  • BionessInc

  • EnteroMedicsInc

  • Nevro Corporation and NeuroPaceInc


Neuromodulation market to reach 11 717 million by 2022

NEUROMODULATION MARKET KEY DRIVERS


Neuromodulation market to reach 11 717 million by 2022

TOP INVESTMENT POCKETS IN WORLD NEUROMODULATION MARKET


Neuromodulation market to reach 11 717 million by 2022

NEUROMODULATION MARKET FOR TREMOR, BY GEOGRAPHY, 2014-2022


Neuromodulation market to reach 11 717 million by 2022

NEUROMODULATION MARKET BY REGION

  • North America, Europe, Asia-Pacific, LAMEA


Neuromodulation market to reach 11 717 million by 2022

Thank You!

For More Details

Visit us at

https://www.alliedmarketresearch.com/neurostimulation-devices-market

Follow Us On


  • Login